I am purely speculating from timing of the PR (today) and how the market typically interprets such news release. If indeed positive, they would have said so in today's PR with further details to be shared on the CC. Hardly any biotech I know that doesn't want to capitalize on a positive development prior to market open.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.